文献速递其他结缔组织病

极早期系统性硬化症中循环胶原转换标志物的失调

Dysregulation of circulating collagen turnover markers in very early systemic sclerosis.
PubMed 文献 · RMD Open · 2024-05-28

研究纳入42例极早期系统性硬化症(veSSc)患者与29名健康对照,采用ELISA检测血清中细胞外基质降解与形成标志物。结果显示veSSc患者III型与IV型胶原转换明显失调,C3M、C4M、PRO-C3升高而转换比值降低,ROC分析示III型与IV型胶原标志物可极好区分veSSc与健康对照。

要点

  • veSSc患者血清C3M、C4M均高于健康对照(均p<0.0001),PRO-C3亦升高(p=0.004)。
  • veSSc患者转换比值PRO-C3/C3M与PRO-C4/C4M均低于健康对照(均p<0.0001)。
  • C3M、C4M及PRO-C4/C4M区分veSSc与健康对照的AUC分别为0.95、0.97、0.97(均p<0.0001)。

核心结论

  • 研究提示细胞外基质重塑是系统性硬化症极早期现象,与微血管及自身免疫改变并行发生。
  • III型与IV型胶原标志物可区分veSSc患者与健康对照,提示其作为检测veSSc的潜在生物标志物。

研究设计与样本

  • 横断面基线分析及纵向分析,纳入42例极早期系统性硬化症(veSSc)患者与29名健康对照(HCs)。
  • veSSc定义为存在雷诺现象且至少具备肿胀手指、抗核抗体阳性或甲襞毛细血管镜异常之一,但不满足2013年美国风湿病学会/欧洲抗风湿病联盟系统性硬化症分类标准。
  • 采用ELISA检测血清中细胞外基质降解标志物(BGM、C3M、C4M、C6M)与形成标志物(PRO-C3、PRO-C4、PRO-C5)。

主要发现

  • 与健康对照相比,veSSc患者III型与IV型胶原转换强烈失调:C3M、C4M均升高(均p<0.0001),PRO-C3升高(p=0.004),转换比值PRO-C3/C3M与PRO-C4/C4M均降低(均p<0.0001)。
  • 双糖链蛋白聚糖降解标志物BGM在veSSc患者中高于健康对照(p=0.006),而VI型胶原降解标志物C6M在veSSc患者中低于健康对照(p=0.002)。
  • ROC分析中,III型与IV型胶原标志物极好区分veSSc与健康对照:C3M的AUC=0.95(p<0.0001),C4M的AUC=0.97(p<0.0001),转换比值PRO-C3/C3M的AUC=0.80(p<0.0001),PRO-C4/C4M的AUC=0.97(p<0.0001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Clinical observation suggests that vascular activation and autoimmunity precede remodelling of the extracellular matrix (ECM) in systemic sclerosis (SSc). We challenge this paradigm by hypothesising that ECM biomarkers are already disturbed in patients with very early SSc (veSSc) when fibrosis is not yet clinically detectable. METHODS: 42 patients with veSSc, defined as the presence of Raynaud's phenomenon and at least one of puffy fingers, positive antinuclear antibodies or pathological nailfold capillaroscopy, not meeting the 2013 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for SSc, were compared with healthy controls (HCs, n=29). ECM degradation (BGM, C3M, C4M and C6M) and ECM formation biomarkers (PRO-C3, PRO-C4 and PRO-C5) were measured in serum using ELISAs. A cross-sectional analysis at baseline and a longitudinal analysis was performed. RESULTS: Compared with HC, veSSc patients showed a strongly dysregulated turnover of type III and IV collagens (higher C3M, C4M, both p<0.0001 and PRO-C3, p=0.004, lower turnover ratios PRO-C3/C3M and PRO-C4/C4M, both p<0.0001). The biglycan degradation biomarker BGM was higher in veSSc than in HC (p=0.006), whereas the degradation biomarker for type VI collagen, C6M, was lower (p=0.002). In an ROC analysis, biomarkers of type III and IV collagen excellently distinguished between veSSc and HC: C3M, AUC=0.95, p<0.0001; C4M, AUC=0.97, p<0.0001; turnover ratios PRO-C3/C3M, AUC=0.80, p<0.0001; PRO-C4/C4M, AUC=0.97; p<0.0001. CONCLUSION: These findings indicate ECM remodelling as a very early phenomenon of SSc occurring in parallel with microvascular and autoimmune changes. Biomarkers of type III and IV collagens distinguished between veSSc patients and HC, indicating them as potential biomarkers for the detection of veSSc.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Dobrota R, Jordan S, Juhl P, et al. Dysregulation of circulating collagen turnover markers in very early systemic sclerosis. RMD Open. 2024. PMID: 38806188. doi:10.1136/rmdopen-2023-003306

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。